Avantor Results Presentation Deck

Summary Li Strong business momentum Robust revenue, earnings growth and EBITDA margin expansion Sequential quarter over quarter growth in core business. Ongoing deleveraging - Executing on our growth strategy Actively deploying capital for M&A to enhance our proprietary portfolio Continued focus on Biopharma including investment in manufacturing capacity and new product introductions Looking ahead Attractive end market exposure, focusing on value-creation framework Strong outlook across key financial metrics for FY21 Balance sheet strength enabling financial flexibility - avantor M 11

View entire presentation